+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cardiovascular Anastomosis Devices Market by Product Type, Mechanism, Procedure Type, End User - Global Forecast to 2030- Product Image
Cardiovascular Anastomosis Devices Market by Product Type, Mechanism, Procedure Type, End User - Global Forecast to 2030- Product Image
Sale

Cardiovascular Anastomosis Devices Market by Product Type, Mechanism, Procedure Type, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 188 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6010719
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cardiovascular Anastomosis Devices Market grew from USD 1.97 billion in 2024 to USD 2.19 billion in 2025. It is expected to continue growing at a CAGR of 10.73%, reaching USD 3.64 billion by 2030.

Setting the Stage for Breakthroughs in Cardiovascular Anastomosis

Advancements in cardiovascular anastomosis devices are reshaping the way clinicians restore vessel continuity and improve patient outcomes. As demographic trends push demand for minimally invasive techniques, the imperative to develop precision tools that reduce procedural time and enhance hemostasis has never been greater. This report opens with an exploration of how aging populations, rising prevalence of cardiovascular disease, and the shift toward value-based care are converging to drive innovation in clips, staplers, and suturing solutions.

We examine the interplay of key market drivers including technological breakthroughs in polymers, energy delivery platforms, and robotic assistance, as well as evolving regulatory standards that incentivize patient safety and cost efficiency. By contextualizing recent clinical data and mapping the competitive landscape, this introduction highlights the critical inflection points that stakeholders must understand in order to navigate a market characterized by rapid change and heightened performance expectations.

Unveiling the Forces Redefining Anastomosis Device Innovation

In the quest to redefine anastomosis, transformative shifts are underway across clinical practice, research, and manufacturing. The integration of advanced energy-based sealing techniques into staple lines has elevated surgical precision while reducing thermal spread. Simultaneously, the surge of robotic and handheld automated suturing platforms is empowering surgeons to achieve consistent stitch placement and tension control, particularly in minimally invasive cardiac and peripheral procedures. These converging technologies are complemented by next-generation adhesives that mimic physiologic healing, enabling seamless vessel fusion without foreign body retention.

Beyond product innovation, value-based procurement models are prompting hospitals and ambulatory centers to demand outcome-focused performance metrics. This, in turn, fuels collaboration between device developers and payers to establish new reimbursement paradigms. At the same time, supply chain digitalization and additive manufacturing are facilitating localized production of patient-specific clips and rings, shortening lead times and reducing inventory risk. Taken together, these trends represent a fundamental shift from commodity-based purchases toward integrated, data-driven ecosystems that align clinical efficacy with economic value.

Assessing the Ripple Effects of Upcoming US Tariff Changes

The imposition of elevated United States tariffs in 2025 marks a pivotal moment for companies reliant on global sourcing of anastomosis components. Newly revised duty rates on metal and polymer clips, linear and circular stapler cartridges, and specialized suturing instruments will introduce additional cost layers that manufacturers and distributors must absorb or pass through to end users. This recalibration of import economics compels a strategic reassessment of manufacturing footprints, with an emphasis on reshoring critical production steps or establishing domestic partnerships to mitigate exposure.

Moreover, supply chain resilience has assumed newfound urgency. Proactive inventory management and dual-sourcing strategies are being deployed to cushion against potential bottlenecks, while cross-border logistics networks are being reengineered to reduce lead times. Device makers are also exploring tariff reclassification for certain composite materials and negotiating free trade zone provisions to alleviate duty burdens. The net effect is a more complex cost equation that demands agility in procurement, agile contract negotiations, and heightened collaboration with regulatory bodies to secure uninterrupted access to essential anastomosis tools.

Illuminating Market Segmentation to Navigate Diverse Device Domains

A granular view of market segmentation reveals multiple avenues for targeted innovation and market penetration. By product type, the landscape encompasses a spectrum of mechanical and manual solutions that address diverse surgical needs. Clips are subdivided into hemostatic and ligating categories, with hemostatic options further distinguished by metal and polymer materials. Stapling systems include circular and linear variants, the latter available in non-reinforced and reinforced configurations to accommodate tissue thickness and leak risk. Suture devices span traditional manual techniques alongside automated platforms, the latter broken down into handheld and robotic suturing instruments that enhance consistency and speed.

Mechanism segmentation highlights adhesive, clamping, compression, energy-based, and stapling approaches. Adhesives range from fibrin sealants derived from human plasma to synthetic polymers engineered for rapid polymerization. Compression methods utilize anastomotic rings and buckles, including bioabsorbable and metal buckle designs that maintain patency while dissolving over time. Energy-based technologies leverage electrothermal, laser, and ultrasonic modalities to seal vessel walls and reduce thermal damage.

Procedure-focused analysis covers coronary bypass-including off-pump and on-pump techniques-peripheral vascular interventions within carotid, femoropopliteal, and renal territories, as well as valve repair procedures where precision suturing is paramount. End-user segmentation spans ambulatory surgery centers, hospitals, and specialty clinics, each with distinct purchasing criteria and procedural volumes that inform product adoption patterns.

Deciphering Regional Dynamics Shaping Global Market Prospects

Regional dynamics exert a profound influence on anastomosis device adoption and innovation pathways. In the Americas, strong reimbursement frameworks and early adoption of minimally invasive cardiovascular procedures underpin robust demand. Domestic manufacturers benefit from established distribution channels and collaborative relationships with leading academic medical centers that drive clinical validation.

Europe, the Middle East, and Africa present a mosaic of healthcare systems. Western Europe leads in regulatory harmonization and value-based purchasing, while Middle Eastern markets invest heavily in state-of-the-art surgical suites. African regions, though nascent, show growing interest in durable, cost-effective devices and local training initiatives that aim to expand procedural capacity.

Asia-Pacific markets demonstrate remarkable heterogeneity. Japan’s mature medtech environment emphasizes incremental innovation and stringent quality standards. China’s rapidly expanding hospital network and supportive policies for domestic production foster fierce competition. Meanwhile, India’s large patient population and focus on affordable care are accelerating adoption of cost-efficient staples and sutures, often in high-volume surgical centers.

Unraveling Strategic Moves of Pioneering Device Manufacturers

The competitive landscape is defined by both established conglomerates and agile innovators. Leading names have augmented their portfolios through strategic acquisitions, targeting niche technologies such as suture automation and advanced sealants. Cross-sector partnerships between device manufacturers and digital health firms are forging novel service models that combine real-time procedural analytics with device performance feedback.

Some companies are doubling down on R&D investment to develop next-generation energy platforms that promise seamless vessel fusion with minimal collateral tissue injury. Others are expanding installation of robotic surgery suites through partnerships with specialty hospitals, enabling them to bundle instrumentation with software-driven procedural workflows. A handful of emerging players focus on bioabsorbable compression rings and advanced polymer clips, securing patents that could disrupt traditional metal-based product lines.

At the same time, distribution and after-sales service excellence have become pivotal differentiators. Vendors offering integrated instrument tracking, predictive maintenance, and training simulations are securing multi-year contracts with large hospital networks. These initiatives underscore the growing emphasis on total cost of ownership as a critical decision criterion for end users.

Charting a Forward-Looking Roadmap for Industry Leaders

To thrive amid evolving market pressures, industry leaders should prioritize development of modular platforms that can be tailored to both open and minimally invasive procedures. Investing in robotic and handheld automation will differentiate offerings and cater to growing surgeon preference for precision technologies. Simultaneously, diversifying manufacturing footprints-through strategic alliances or greenfield facilities in tariff-sensitive regions-will mitigate import duty exposure and strengthen supply chain resilience.

Deepening engagement with payers and health technology assessment bodies is critical to securing favorable reimbursement pathways. Companies that generate robust real-world evidence, demonstrating reduced complication rates and faster patient recovery, will be best positioned to advocate for value-based contracts. Equally important is the cultivation of comprehensive training programs-leveraging virtual reality simulations-to accelerate surgeon adoption and optimize procedural outcomes.

Finally, harnessing digital tools for instrument tracking and performance analytics will unlock new service-based revenue streams. By integrating data insights into post-market surveillance and customer support, manufacturers can enhance device reliability, anticipate maintenance needs, and foster long-term loyalty among surgical teams.

Ensuring Rigor Through a Robust Research Framework

This report synthesizes insights from a rigorous, multi-phase research process. Primary research included in-depth interviews with cardiovascular surgeons, procurement officers, and regulatory experts across key markets. Secondary research spanned analysis of peer-reviewed journals, regulatory filings, patent databases, and corporate financial statements. Market dynamics were assessed through triangulation, cross-referencing qualitative insights with quantitative data to ensure accuracy and consistency.

A systematic approach to data validation was employed, leveraging custom surveys and advisory board consultations to refine assumptions and interpret emerging trends. Methodological rigor was further reinforced through continuous benchmarking against historical performance indicators and external indices. This framework delivers a transparent, traceable pathway from raw data to strategic recommendations, ensuring that conclusions are both robust and actionable.

Synthesizing Insights to Propel Strategic Decision Making

The cardiovascular anastomosis devices market stands at the intersection of technological innovation, regulatory evolution, and shifting economic pressures. From the rise of automated suturing platforms to the imperative of tariff mitigation, the industry is navigating multiple inflection points that will redefine competitive advantage. Segmentation analysis highlights clear opportunities for product differentiation across clips, staplers, adhesives, and energy-based modalities, while regional insights underscore the need for tailored go-to-market strategies.

Leading companies are responding with strategic acquisitions, enhanced service offerings, and targeted R&D investments. As the landscape continues to evolve, success will hinge on the ability to align clinical efficacy with cost management, forge collaborative reimbursement pathways, and anticipate emerging procedural trends. Stakeholders equipped with a nuanced understanding of these dynamics will be best positioned to capture growth and deliver superior patient outcomes.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Clips
      • Hemostatic Clips
        • Metal Clips
        • Polymer Clips
      • Ligating Clips
    • Staplers
      • Circular Staplers
      • Linear Staplers
        • Non Reinforced
        • Reinforced
    • Suture Devices
      • Automated Suturing
        • Handheld Suturer
        • Robotic Suturer
      • Manual Suturing
  • Mechanism
    • Adhesive
      • Fibrin Sealants
      • Synthetic Sealants
    • Clamping
    • Compression
      • Anastomotic Rings
      • Buckles
        • Bioabsorbable Buckles
        • Metal Buckles
    • Energy Based
      • Electrothermal
      • Laser
      • Ultrasonic
    • Stapling
  • Procedure Type
    • Coronary Bypass
      • Off Pump
      • On Pump
    • Peripheral Vascular
      • Carotid
      • Femoropopliteal
      • Renal
    • Valve Repair
  • End User
    • Ambulatory Surgery Centers
    • Hospitals
    • Specialty Clinics
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Medtronic plc
  • Abbott Laboratories
  • TERUMO Corporation
  • Johnson & Johnson
  • W. L. Gore & Associates, Inc.
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Teleflex Incorporated
  • Getinge AB
  • CryoLife, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cardiovascular Anastomosis Devices Market, by Product Type
8.1. Introduction
8.2. Clips
8.2.1. Hemostatic Clips
8.2.1.1. Metal Clips
8.2.1.2. Polymer Clips
8.2.2. Ligating Clips
8.3. Staplers
8.3.1. Circular Staplers
8.3.2. Linear Staplers
8.3.2.1. Non Reinforced
8.3.2.2. Reinforced
8.4. Suture Devices
8.4.1. Automated Suturing
8.4.1.1. Handheld Suturer
8.4.1.2. Robotic Suturer
8.4.2. Manual Suturing
9. Cardiovascular Anastomosis Devices Market, by Mechanism
9.1. Introduction
9.2. Adhesive
9.2.1. Fibrin Sealants
9.2.2. Synthetic Sealants
9.3. Clamping
9.4. Compression
9.4.1. Anastomotic Rings
9.4.2. Buckles
9.4.2.1. Bioabsorbable Buckles
9.4.2.2. Metal Buckles
9.5. Energy Based
9.5.1. Electrothermal
9.5.2. Laser
9.5.3. Ultrasonic
9.6. Stapling
10. Cardiovascular Anastomosis Devices Market, by Procedure Type
10.1. Introduction
10.2. Coronary Bypass
10.2.1. Off Pump
10.2.2. on Pump
10.3. Peripheral Vascular
10.3.1. Carotid
10.3.2. Femoropopliteal
10.3.3. Renal
10.4. Valve Repair
11. Cardiovascular Anastomosis Devices Market, by End User
11.1. Introduction
11.2. Ambulatory Surgery Centers
11.3. Hospitals
11.4. Specialty Clinics
12. Americas Cardiovascular Anastomosis Devices Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Cardiovascular Anastomosis Devices Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Cardiovascular Anastomosis Devices Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Medtronic plc
15.3.2. Abbott Laboratories
15.3.3. TERUMO Corporation
15.3.4. Johnson & Johnson
15.3.5. W. L. Gore & Associates, Inc.
15.3.6. Baxter International Inc.
15.3.7. B. Braun Melsungen AG
15.3.8. Teleflex Incorporated
15.3.9. Getinge AB
15.3.10. CryoLife, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET MULTI-CURRENCY
FIGURE 2. CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET MULTI-LANGUAGE
FIGURE 3. CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY MECHANISM, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY MECHANISM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY CLIPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY HEMOSTATIC CLIPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY METAL CLIPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY POLYMER CLIPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY HEMOSTATIC CLIPS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY LIGATING CLIPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY CLIPS, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY STAPLERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY CIRCULAR STAPLERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY LINEAR STAPLERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY NON REINFORCED, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY REINFORCED, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY LINEAR STAPLERS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY STAPLERS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY SUTURE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY AUTOMATED SUTURING, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY HANDHELD SUTURER, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY ROBOTIC SUTURER, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY AUTOMATED SUTURING, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY MANUAL SUTURING, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY SUTURE DEVICES, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY ADHESIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY FIBRIN SEALANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY SYNTHETIC SEALANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY ADHESIVE, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY CLAMPING, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY COMPRESSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY ANASTOMOTIC RINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY BUCKLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY BIOABSORBABLE BUCKLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY METAL BUCKLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY BUCKLES, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY COMPRESSION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY ENERGY BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY ELECTROTHERMAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY LASER, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY ULTRASONIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY ENERGY BASED, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY STAPLING, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY CORONARY BYPASS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY OFF PUMP, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY ON PUMP, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY CORONARY BYPASS, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PERIPHERAL VASCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY CAROTID, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY FEMOROPOPLITEAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY RENAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY VALVE REPAIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY CLIPS, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY HEMOSTATIC CLIPS, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY STAPLERS, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY LINEAR STAPLERS, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY SUTURE DEVICES, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY AUTOMATED SUTURING, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY ADHESIVE, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY COMPRESSION, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY BUCKLES, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY ENERGY BASED, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY CORONARY BYPASS, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY CLIPS, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY HEMOSTATIC CLIPS, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY STAPLERS, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY LINEAR STAPLERS, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY SUTURE DEVICES, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY AUTOMATED SUTURING, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY ADHESIVE, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY COMPRESSION, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY BUCKLES, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY ENERGY BASED, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY CORONARY BYPASS, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 96. CANADA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 97. CANADA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY CLIPS, 2018-2030 (USD MILLION)
TABLE 98. CANADA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY HEMOSTATIC CLIPS, 2018-2030 (USD MILLION)
TABLE 99. CANADA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY STAPLERS, 2018-2030 (USD MILLION)
TABLE 100. CANADA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY LINEAR STAPLERS, 2018-2030 (USD MILLION)
TABLE 101. CANADA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY SUTURE DEVICES, 2018-2030 (USD MILLION)
TABLE 102. CANADA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY AUTOMATED SUTURING, 2018-2030 (USD MILLION)
TABLE 103. CANADA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 104. CANADA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY ADHESIVE, 2018-2030 (USD MILLION)
TABLE 105. CANADA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY COMPRESSION, 2018-2030 (USD MILLION)
TABLE 106. CANADA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY BUCKLES, 2018-2030 (USD MILLION)
TABLE 107. CANADA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY ENERGY BASED, 2018-2030 (USD MILLION)
TABLE 108. CANADA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 109. CANADA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY CORONARY BYPASS, 2018-2030 (USD MILLION)
TABLE 110. CANADA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2030 (USD MILLION)
TABLE 111. CANADA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. MEXICO CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 113. MEXICO CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY CLIPS, 2018-2030 (USD MILLION)
TABLE 114. MEXICO CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY HEMOSTATIC CLIPS, 2018-2030 (USD MILLION)
TABLE 115. MEXICO CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY STAPLERS, 2018-2030 (USD MILLION)
TABLE 116. MEXICO CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY LINEAR STAPLERS, 2018-2030 (USD MILLION)
TABLE 117. MEXICO CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY SUTURE DEVICES, 2018-2030 (USD MILLION)
TABLE 118. MEXICO CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY AUTOMATED SUTURING, 2018-2030 (USD MILLION)
TABLE 119. MEXICO CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 120. MEXICO CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY ADHESIVE, 2018-2030 (USD MILLION)
TABLE 121. MEXICO CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY COMPRESSION, 2018-2030 (USD MILLION)
TABLE 122. MEXICO CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY BUCKLES, 2018-2030 (USD MILLION)
TABLE 123. MEXICO CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY ENERGY BASED, 2018-2030 (USD MILLION)
TABLE 124. MEXICO CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 125. MEXICO CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY CORONARY BYPASS, 2018-2030 (USD MILLION)
TABLE 126. MEXICO CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2030 (USD MILLION)
TABLE 127. MEXICO CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY CLIPS, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY HEMOSTATIC CLIPS, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY STAPLERS, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY LINEAR STAPLERS, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY SUTURE DEVICES, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY AUTOMATED SUTURING, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY ADHESIVE, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY COMPRESSION, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY BUCKLES, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY ENERGY BASED, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY CORONARY BYPASS, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. ARGENTINA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 145. ARGENTINA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY CLIPS, 2018-2030 (USD MILLION)
TABLE 146. ARGENTINA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY HEMOSTATIC CLIPS, 2018-2030 (USD MILLION)
TABLE 147. ARGENTINA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY STAPLERS, 2018-2030 (USD MILLION)
TABLE 148. ARGENTINA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY LINEAR STAPLERS, 2018-2030 (USD MILLION)
TABLE 149. ARGENTINA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY SUTURE DEVICES, 2018-2030 (USD MILLION)
TABLE 150. ARGENTINA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY AUTOMATED SUTURING, 2018-2030 (USD MILLION)
TABLE 151. ARGENTINA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 152. ARGENTINA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY ADHESIVE, 2018-2030 (USD MILLION)
TABLE 153. ARGENTINA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY COMPRESSION, 2018-2030 (USD MILLION)
TABLE 154. ARGENTINA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY BUCKLES, 2018-2030 (USD MILLION)
TABLE 155. ARGENTINA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY ENERGY BASED, 2018-2030 (USD MILLION)
TABLE 156. ARGENTINA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 157. ARGENTINA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY CORONARY BYPASS, 2018-2030 (USD MILLION)
TABLE 158. ARGENTINA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2030 (USD MILLION)
TABLE 159. ARGENTINA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY CLIPS, 2018-2030 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY HEMOSTATIC CLIPS, 2018-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY STAPLERS, 2018-2030 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY LINEAR STAPLERS, 2018-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY SUTURE DEVICES, 2018-2030 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY AUTOMATED SUTURING, 2018-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY ADHESIVE, 2018-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY COMPRESSION, 2018-2030 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY BUCKLES, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY ENERGY BASED, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY CORONARY BYPASS, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 178. UNITED KINGDOM CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY CLIPS, 2018-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY HEMOSTATIC CLIPS, 2018-2030 (USD MILLION)
TABLE 180. UNITED KINGDOM CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY STAPLERS, 2018-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY LINEAR STAPLERS, 2018-2030 (USD MILLION)
TABLE 182. UNITED KINGDOM CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY SUTURE DEVICES, 2018-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY AUTOMATED SUTURING, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY ADHESIVE, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY COMPRESSION, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY BUCKLES, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY ENERGY BASED, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY CORONARY BYPASS, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. GERMANY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 194. GERMANY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY CLIPS, 2018-2030 (USD MILLION)
TABLE 195. GERMANY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY HEMOSTATIC CLIPS, 2018-2030 (USD MILLION)
TABLE 196. GERMANY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY STAPLERS, 2018-2030 (USD MILLION)
TABLE 197. GERMANY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY LINEAR STAPLERS, 2018-2030 (USD MILLION)
TABLE 198. GERMANY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY SUTURE DEVICES, 2018-2030 (USD MILLION)
TABLE 199. GERMANY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY AUTOMATED SUTURING, 2018-2030 (USD MILLION)
TABLE 200. GERMANY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 201. GERMANY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY ADHESIVE, 2018-2030 (USD MILLION)
TABLE 202. GERMANY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY COMPRESSION, 2018-2030 (USD MILLION)
TABLE 203. GERMANY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY BUCKLES, 2018-2030 (USD MILLION)
TABLE 204. GERMANY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY ENERGY BASED, 2018-2030 (USD MILLION)
TABLE 205. GERMANY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 206. GERMANY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY CORONARY BYPASS, 2018-2030 (USD MILLION)
TABLE 207. GERMANY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2030 (USD MILLION)
TABLE 208. GERMANY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. FRANCE CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 210. FRANCE CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY CLIPS, 2018-2030 (USD MILLION)
TABLE 211. FRANCE CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY HEMOSTATIC CLIPS, 2018-2030 (USD MILLION)
TABLE 212. FRANCE CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY STAPLERS, 2018-2030 (USD MILLION)
TABLE 213. FRANCE CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY LINEAR STAPLERS, 2018-2030 (USD MILLION)
TABLE 214. FRANCE CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY SUTURE DEVICES, 2018-2030 (USD MILLION)
TABLE 215. FRANCE CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY AUTOMATED SUTURING, 2018-2030 (USD MILLION)
TABLE 216. FRANCE CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 217. FRANCE CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY ADHESIVE, 2018-2030 (USD MILLION)
TABLE 218. FRANCE CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY COMPRESSION, 2018-2030 (USD MILLION)
TABLE 219. FRANCE CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY BUCKLES, 2018-2030 (USD MILLION)
TABLE 220. FRANCE CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY ENERGY BASED, 2018-2030 (USD MILLION)
TABLE 221. FRANCE CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 222. FRANCE CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY CORONARY BYPASS, 2018-2030 (USD MILLION)
TABLE 223. FRANCE CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2030 (USD MILLION)
TABLE 224. FRANCE CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 225. RUSSIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY CLIPS, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY HEMOSTATIC CLIPS, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY STAPLERS, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY LINEAR STAPLERS, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY SUTURE DEVICES, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY AUTOMATED SUTURING, 2018-2030 (USD MILLION)
TABLE 232. RUSSIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 233. RUSSIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY ADHESIVE, 2018-2030 (USD MILLION)
TABLE 234. RUSSIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY COMPRESSION, 2018-2030 (USD MILLION)
TABLE 235. RUSSIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY BUCKLES, 2018-2030 (USD MILLION)
TABLE 236. RUSSIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY ENERGY BASED, 2018-2030 (USD MILLION)
TABLE 237. RUSSIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 238. RUSSIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY CORONARY BYPASS, 2018-2030 (USD MILLION)
TABLE 239. RUSSIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2030 (USD MILLION)
TABLE 240. RUSSIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 241. ITALY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 242. ITALY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY CLIPS, 2018-2030 (USD MILLION)
TABLE 243. ITALY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY HEMOSTATIC CLIPS, 2018-2030 (USD MILLION)
TABLE 244. ITALY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY STAPLERS, 2018-2030 (USD MILLION)
TABLE 245. ITALY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY LINEAR STAPLERS, 2018-2030 (USD MILLION)
TABLE 246. ITALY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY SUTURE DEVICES, 2018-2030 (USD MILLION)
TABLE 247. ITALY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY AUTOMATED SUTURING, 2018-2030 (USD MILLION)
TABLE 248. ITALY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 249. ITALY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY ADHESIVE, 2018-2030 (USD MILLION)
TABLE 250. ITALY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY COMPRESSION, 2018-2030 (USD MILLION)
TABLE 251. ITALY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY BUCKLES, 2018-2030 (USD MILLION)
TABLE 252. ITALY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY ENERGY BASED, 2018-2030 (USD MILLION)
TABLE 253. ITALY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 254. ITALY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY CORONARY BYPASS, 2018-2030 (USD MILLION)
TABLE 255. ITALY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2030 (USD MILLION)
TABLE 256. ITALY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. SPAIN CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 258. SPAIN CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY CLIPS, 2018-2030 (USD MILLION)
TABLE 259. SPAIN CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY HEMOSTATIC CLIPS, 2018-2030 (USD MILLION)
TABLE 260. SPAIN CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY STAPLERS, 2018-2030 (USD MILLION)
TABLE 261. SPAIN CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY LINEAR STAPLERS, 2018-2030 (USD MILLION)
TABLE 262. SPAIN CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY SUTURE DEVICES, 2018-2030 (USD MILLION)
TABLE 263. SPAIN CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY AUTOMATED SUTURING, 2018-2030 (USD MILLION)
TABLE 264. SPAIN CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 265. SPAIN CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY ADHESIVE, 2018-2030 (USD MILLION)
TABLE 266. SPAIN CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY COMPRESSION, 2018-2030 (USD MILLION)
TABLE 267. SPAIN CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY BUCKLES, 2018-2030 (USD MILLION)
TABLE 268. SPAIN CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY ENERGY BASED, 2018-2030 (USD MILLION)
TABLE 269. SPAIN CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 270. SPAIN CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY CORONARY BYPASS, 2018-2030 (USD MILLION)
TABLE 271. SPAIN CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2030 (USD MILLION)
TABLE 272. SPAIN CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY CLIPS, 2018-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY HEMOSTATIC CLIPS, 2018-2030 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY STAPLERS, 2018-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY LINEAR STAPLERS, 2018-2030 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY SUTURE DEVICES, 2018-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY AUTOMATED SUTURING, 2018-2030 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY ADHESIVE, 2018-2030 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY COMPRESSION, 2018-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY BUCKLES, 2018-2030 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY ENERGY BASED, 2018-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY CORONARY BYPASS, 2018-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2030 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 289. SAUDI ARABIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 290. SAUDI ARABIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY CLIPS, 2018-2030 (USD MILLION)
TABLE 291. SAUDI ARABIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY HEMOSTATIC CLIPS, 2018-2030 (USD MILLION)
TABLE 292. SAUDI ARABIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY STAPLERS, 2018-2030 (USD MILLION)
TABLE 293. SAUDI ARABIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY LINEAR STAPLERS, 2018-2030 (USD MILLION)
TABLE 294. SAUDI ARABIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY SUTURE DEVICES, 2018-2030 (USD MILLION)
TABLE 295. SAUDI ARABIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY AUTOMATED SUTURING, 2018-2030 (USD MILLION)
TABLE 296. SAUDI ARABIA

Companies Mentioned

The companies profiled in this Cardiovascular Anastomosis Devices market report include:
  • Medtronic plc
  • Abbott Laboratories
  • TERUMO Corporation
  • Johnson & Johnson
  • W. L. Gore & Associates, Inc.
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Teleflex Incorporated
  • Getinge AB
  • CryoLife, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages188
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.19 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.64 Billion
Compound Annual Growth Rate10.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Anastomosis Device - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Anastomosis Device - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Anastomosis Devices Market by Application, End Use, Technology, Procedure Type, Distribution Channel, Material Type - Global Forecast to 2030 - Product Image

Anastomosis Devices Market by Application, End Use, Technology, Procedure Type, Distribution Channel, Material Type - Global Forecast to 2030

  • Report
  • 189 Pages
  • Global
From
Anastomosis Devices - Global Strategic Business Report - Product Image

Anastomosis Devices - Global Strategic Business Report

  • Report
  • 93 Pages
  • Global
From
Anastomosis Devices Market Report 2025 - Product Image

Anastomosis Devices Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Anastomosis Devices Market Size, Share & Trends Analysis Report By Product, By Application (Cardiovascular Surgery, Gastro-intestinal Surgery), By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Anastomosis Devices Market Size, Share & Trends Analysis Report By Product, By Application (Cardiovascular Surgery, Gastro-intestinal Surgery), By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From

About the Market

Cardiovascular Anastomosis Devices are medical devices used to connect two blood vessels or other tubular structures in the cardiovascular system. These devices are used to bypass blocked or damaged vessels, to restore blood flow, and to repair congenital heart defects. They are also used to create a shunt between two vessels to divert blood flow. The devices are typically made of biocompatible materials such as polytetrafluoroethylene (PTFE) and Dacron. The Cardiovascular Anastomosis Devices market is a subset of the larger Cardiovascular Devices market. It is a rapidly growing market, driven by the increasing prevalence of cardiovascular diseases, technological advancements, and the growing demand for minimally invasive procedures. Some of the major companies in the Cardiovascular Anastomosis Devices market include Medtronic, Johnson & Johnson, Boston Scientific, Terumo Corporation, and Abbott Laboratories. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.